These findings demonstrate that, knockdown of PPAR δ promotes the growth of colon cancer by lessening the differentiation and promoting the proliferation as well as VEGF expression of tumor cells in vivo, and reduces tumor sensitivity to bevacizumab. Here, VEGFA is linked to malignant colon neoplasm.